Alarcon, G. S. 1992. Arthritis due to tuberculosis, fungal infections, and parasites. Current Opinion in Rheumatology 4, no. 4:516-519.
Albano, S. A.; E. Santana-Sahagun; and M. H. Weisman. 2001. Cigarette smoking and rheumatoid arthritis. Seminars in Arthritis & Rheumatism 31, no. 3:146-159.
Alehtaha, D., and J. S. Smolen. 2002. Laboratory testing in rheumatoid arthritis patients taking disease-modifying antirheumatic drugs: Clinical evaluation and cost analysis. Arthritis & Rheumatism 47, no. 2:181-188.
Allcock, R. J.; J. J. O'Sullivan; and P. A. Corris. 2001. Palliation of systemic sclerosis-associated pulmonary hypertension by atrial septostomy. Arthritis & Rheumatism 44, no. 7:1,660-1,662.
American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. 2002. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis & Rheumatism 46, no. 2:328-346.
Badesch, D. B.; V. F. Tapson; M. D. McGoon; et al. 2000. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Annals of Internal Medicine 132, no. 6:425-434.
Barnett, M. L.; J. M. Kremer, Sr., D. O. Clegg; et al. 1998. Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial. Arthritis & Rheumatism 41, no. 2:290-297.
Barrett, J. H.; P. Brennan; M. Fiddler; and A. Silman. 2000. Breast-feeding and postpartum relapse in women with rheumatoid and inflammatory arthritis. Arthritis & Rheumatism 43, no. 5:1,010-1,015.
Bennett, M. L.; J. M. Jackson; J. L. Jorizzo; et al. 2000. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine 79, no. 1:37-46.
Berman, A.; P. Cahn; H. Perez; et al. 1999. Human immunodeficiency virus infection associated arthritis: clinical characteristics. [see comments.]. Journal of Rheumatology 26, no. 5:1,158-1,162.
Berman, B. M.; J. P. Swyers; and J. Ezzo. 2000. The evidence for acupuncture as a treatment for rheumato-logic conditions. Rheumatic Diseases Clinics of North America 26, no. 1:103-115.
Bingham, S.; D. Veale; U. Fearon; et al. 2002. High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: Short-term efficacy correlates with reduction of macroscopic and histologic synovi-tis. Arthritis & Rheumatism 46, no. 3:837-839.
Boers, M.; A. C. Verhoeven; H. M. Markusse. 1997. Randomised comparison of combined step-down pred-nisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 350, no. 9,074:309-318.
Bolster, M. B. and R. M. Silver. 1999. Assessment and management of scleroderma lung disease. Current Opinion in Rheumatology 11, no. 6:508-513.
Borenstein, D. G. 2001. Epidemiology, etiology, diagnostic evaluation, and treatment of low back pain. Current Opinion in Rheumatology 13, no. 2:128-134.
Broderick, J. E. 2000. Mind-body medicine in rheumato-logic disease. Rheumatic Diseases Clinics of North America 26, no. 1:161-176.
Buskila, D. 2000. Hepatitis C-associated arthritis. Current Opinion in Rheumatology 12, no. 4:295-299.
--. Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. Current Opinion in Rheumatology 13, no. 2:117-127.
Calabrese, L. H. 1991. Vasculitis and infection with the human immunodeficiency virus. Rheumatic Diseases Clinics of North America 17, no. 1:131-147.
Calabrese, L. H.; G. F. Duna; and J. T. Lie. 1997. Vasculitis in the central nervous system. Arthritis & Rheumatism 40, no. 7:1,189-1,201.
Callen, J. P. 1998. Pyoderma gangrenosum. Lancet 351, no. 9,102:581-585.
Campion, E. W. 1992. Desperate diseases and plasma-pheresis. New England Journal of Medicine 326, no. 21:1,425-1,427.
Cassidy, J. T. 1999. Medical management of children with juvenile rheumatoid arthritis. Drugs 58, no. 5:831-850.
Chariot, P.; E. Ruet; F. J. Authier; Y. Levy; and R. Gher-ardi. 1994. Acute rhabdomyolysis in patients infected by human immunodeficiency virus. Neurology 44, no. 9:1,692-1,696.
Cines, D. B., and V. S. Blanchette. 2002. Immune thrombocytopenic purpura. New England Journal of Medicine 346, no. 13:995-1,008.
Clark, W. F.; G. A. Rock; N. Buskard; et al. 1999. Therapeutic plasma exchange: An update from the Canadian Apheresis Group. Annals of Internal Medicine 131, no. 6:453-462.
Cohen, M. D., and A. Abril. 2001. Polymyalgia rheumat-ica revisited. Bulletin on the Rheumatic Diseases 50, no. 8:1-4.
Cohen, S.; E. Hurd; J. Cush; et al. 2002. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: Results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Arthritis & Rheumatism 46, no. 3:614-624.
Cuellar, M. L. 1998. HIV infection-associated inflammatory musculoskeletal disorders. Rheumatic Diseases Clinics of North America 24, no. 2:403-421.
Cush, J. J.; A. F. Kavanaugh; N. J. Olsen; et al. 1999. Rheumatology: Diagnosis and Therapeutics. Baltimore: Williams and Wilkins.
Daikh, B. E., and M. M. Holyst. 2001. Lupus-specific autoantibodies in concomitant human immunodeficiency virus and systemic lupus erythematosus: Case report and literature review. Seminars in Arthritis & Rheumatism 30, no. 6:418-425.
Delmas, P. D. 2002. Treatment of postmenopausal osteoporosis. Lancet 359, no. 9,322:2,018-2,026.
Delmas, P. D., and P. J. Meunier. 1997. The management of Paget's disease of bone. New England Journal of Medicine 336, no. 8:558-566.
Deyo, R. A. 2002. Diagnostic evaluation of LBP: Reaching a specific diagnosis is often impossible. Archives of Internal Medicine 162, no. 13:1,444-1,447.
Deyo, R. A., and J. N. Weinstein. 2001. Low back pain. New England Journal of Medicine 344, no. 5:363-370.
Drenth, J. P., and J. W. van der Meer. 2001. Hereditary periodic fever. New England Journal of Medicine 345, no. 24:1,748-1,757.
Eastell, R. 1998. Treatment of postmenopausal osteoporosis. New England Journal of Medicine 338, no. 11:736-746.
Eisenberg, S.; I. Aksentijevich; Z. Deng; D. L. Kastner; and Y. Matzner. 1998. Diagnosis of familial Mediterranean fever by a molecular genetics method. Annals of Internal Medicine 129, no. 7:539-542.
Erhardt, A.; A. Sagir; L. Guillevin; E. Neuen-Jacob; and D. Haussinger. 2000. Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, alpha-interferon and lamivu-dine. Journal of Hepatology 33, no. 4:677-683.
Espinoza, L. R.; J. L. Aguilar; C. G. Espinoza; et al. 1991. Characteristics and pathogenesis of myositis in human immunodeficiency virus infection—distinction from azidothymidine-induced myopathy. Rheumatic Diseases Clinics of North America 17, no. 1:117-129.
Evans, J. M., and G. G. Hunder. 2000. Polymyalgia rheumatica and giant cell arteritis. Rheumatic Diseases Clinics of North America 26, no. 3:493-515.
Felson, D. T.; Y. Zhang; M. T. Hannan; et al. The incidence and natural history of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis & Rheumatism 38, no. 10:1,500-1,505.
Fiechtner, J. J., and R. R. Brodeur. 2000. Manual and manipulation techniques for rheumatic disease. Rheumatic Diseases Clinics of North America 26, no. 1:83-96.
FitzGerald, G. A., and C. Patrono. 2001. The coxibs, selective inhibitors of cyclooxygenase-2. New England Journal of Medicine 345, no. 6:433-442.
Font, C.; O. Miro; E. Pedrol; et al. 1996. Polyarteritis nodosa in human immunodeficiency virus infection: Report of four cases and review of the literature. British Journal of Rheumatology 35, no. 8:796-799.
Fox, R. I.; M. Stern; and P. Michelson. 2000. Update in Sjögren syndrome. Current Opinion in Rheumatology 12, no. 5:391-398.
Furst, D. E. 2002. Stem cell transplantation for autoimmune disease: Progress and problems. Current Opinion in Rheumatology 14, no. 3:220-224.
Furst, D. E.; E. C. Keystone; F. C. Breedveld; et al. 2001. Updated consensus statement on tumor necrosis factor blocking agents for the treatment of rheumatoid arthritis and other rheumatic diseases (April 2001). Annals of the Rheumatic Diseases 60 Suppl 3:iii2-iii5.
Gabel, G. T. 1999. Acute and chronic tendinopathies at the elbow. Current Opinion in Rheumatology 11, no. 2:138-143.
Gabriel, S. E. 2001. The epidemiology of rheumatoid arthritis. Rheumatic Diseases Clinics of North America 27, no. 2:269-281.
Garfinkel, M., and H. R. Schumacher, Jr. 2000. Yoga.
Rheumatic Diseases Clinics of North America 26, no. 1:125-132.
George, J. N.; M. A. el Harake; and G. E. Raskob. 1994. Chronic idiopathic thrombocytopenic purpura. New
England Journal of Medicine 331, no. 18:1,207-1,211.
George, J. N.; G. E. Raskob; S. R. Shah; et al. 1998. Drug-induced thrombocytopenia: A systematic review of published case reports. Annals of Internal Medicine 129, no. 11:886-890.
Gertz, M. A.; M. Q. Lacy; and A. Dispenzieri. 1999. Amyloidosis: Recognition, confirmation, prognosis, and therapy. Mayo Clinic Proceedings 74, no. 5:490-494.
Gloth, M. J., and A. M. Matesi. 2001. Physical therapy and exercise in pain management. Clinics in Geriatric Medicine 17, no. 3:525-535.
Goldenberg, D. L. 1999. Fibromyalgia syndrome a decade later: What have we learned? Archives of Internal Medicine 159, no. 8:777-785.
Guillevin, L. 1999. Virus-associated vasculitides. Rheumatology 38, no. 7:588-590.
Guzman, J.; R. Esmail; K. Karjalainen; et al. 2001. Multi-disciplinary rehabilitation for chronic low back pain: Systematic review. BMJ 322, no. 7,301:1,511-1,516.
Hadler, N. M. 2000. Chiropractic. Rheumatic Diseases Clinics of North America 26, no. 1:97-102.
Hertzman, P. A.; D. J. Clauw; L. D. Kaufman; et al. 1995. The eosinophilia-myalgia syndrome: Status of 205 patients and results of treatment 2 years after onset. Annals of Internal Medicine 122, no. 11:851-855.
Hertzman, P. A.; H. Falk; E. M. Kilbourne; S. Page; and L. E. Shulman. 1991. The eosinophilia-myalgia syndrome: The Los Alamos Conference. Journal of Rheumatology 18, no. 6:867-873.
Hoffman, G. S. 1997. Treatment of Wegener's granulo-matosis: Time to change the standard of care? Arthritis & Rheumatism 40, no. 12:2,099-2,104.
Hoffman, G. S.; M. C. Cid; D. B. Hellmann; et al. 2002. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis & Rheumatism 46, no. 5:1,309-1,318.
Hoffman, G. S.; G. S. Kerr; R. Y. Leavitt; et al. 1992. Wegener granulomatosis: An analysis of 158 patients. Annals of Internal Medicine 116, no. 6:488-498.
Hoffman, G. S.; R. Y. Leavitt; G. S. Kerr; and A. S. Fauci. 1992. The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate. Arthritis & Rheumatism 35, no. 11:1,322-1,329.
Hurwitz, S. R. 1996. Case management study: Heel pain in the adult. Bulletin on the Rheumatic Diseases 45, no. 4:1-3.
Ilowite, N. T. 2002. Current treatment of juvenile rheumatoid arthritis. Pediatrics 109, no. 1:109-115.
Janowsky, E. C.; L. L. Kupper; and B. S. Hulka. 2000. Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. New England Journal of Medicine 342, no. 11:781-790.
Janssen, N. M., and M. S. Genta. 2000. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Archives of Internal Medicine 160, no. 5:610-619.
Jonas, W. B.; K. Linde; and G. Ramirez. 2000. Homeopathy and rheumatic disease. Rheumatic Diseases Clinics of North America 26, no. 1:117-123.
Kaptchuk, T. J. 2002. Acupuncture: Theory, efficacy, and practice. Annals of Internal Medicine 136, no. 5:374-383.
Katz, J. N., and B. P. Simmons. 2002. Clinical practice. Carpal tunnel syndrome. New England Journal of Medicine 346, no. 23:1,807-1,812.
Kemler, M. A.; G. A. Barendse; M. van Kleef; et al. 2000. Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine 343, no. 9:618-624.
Kerr, G. S.; C. W. Hallahan; J. Giordano; et al. 1994. Takayasu arteritis. Annals of Internal Medicine 120, no. 11:919-929.
Khan, M. A. 2002. Update on spondyloarthropathies. Annals of Internal Medicine 136, no. 12:896-907.
Kirwan, J. R. 2001. Systemic low-dose glucocorticoid treatment in rheumatoid arthritis. Rheumatic Diseases Clinics of North America 27, no. 2:389-403.
Klinger, G.; Y. Morad; C. A. Westall; et al. 2001. Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases. Lancet 358, no. 9,284:813-814.
Klings, E. S.; N. S. Hill; M. H. Ieong; et al. 1999. Systemic sclerosis-associated pulmonary hypertension: Short-and long-term effects of epoprostenol (prostacyclin). Arthritis & Rheumatism 42, no. 12:2,638-2,645.
Klippel, J. H. 1997. Systemic lupus erythematosus: Demographics, prognosis, and outcome. Journal of Rheumatology—Supplement 48:67-71.
Koren, G.; A. Pastuszak; and S. Ito. 1998. Drugs in pregnancy. New England Journal of Medicine 338, no. 16:1,128-1,137.
Kremer, J. M. 1997. Safety, efficacy, and mortality in a long-term cohort of patients with rheumatoid arthritis taking methotrexate: Followup after a mean of 13.3 years. Arthritis & Rheumatism 40, no. 5:984-985.
Kremer, J. M.; G. S. Alarcon; R. W. Lightfoot Jr.; et al. 1994. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Arthritis & Rheumatism 37, no. 3:316-328.
Kremer, J. M.; G. S. Alarcon; M. E. Weinblatt; et al. 1997. Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: A multicenter study with literature review Arthritis & Rheumatism 40, no. 10:1,829-1,837.
Langford, C. A. 2001. Treatment of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: Where do we stand? Arthritis & Rheumatism 44, no. 3:508-512.
--. 2001. Wegener granulomatosis. American Journal of the Medical Sciences 321, no. 1:76-82.
Lauer, G. M., and B. D. Walker. 2001. Hepatitis C virus infection. New England Journal of Medicine 345, no. 1:41-52.
Lee, D. M., and M. E. Weinblatt. 2001. Rheumatoid arthritis. Lancet 358, no. 9,285:903-911.
Leighton, C. 2001. Drug treatment of scleroderma. Drugs 61, no. 3:419-427.
Leventhal, L. J. 1999. Management of fibromyalgia. Annals of Internal Medicine 131, no. 11:850-858.
Levine, J. S.; D. W. Branch; and J. Rauch. 2002. The antiphospholipid syndrome. New England Journal of Medicine 346, no. 10:752-763.
Lunardi, C.; C. Bason; M. Leandri; et al. 2002. Autoanti-bodies to inner ear and endothelial antigens in Cogan's syndrome. Lancet. 360, no. 9,337:915.
Maddison; P. J.; D. A. Isenberg; P. Woo; and D. N. Glass. 1998. Oxford Textbook of Rheumatology 2nd edition. New York: Oxford University Press.
Mader, J. T.; D. Mohan; and J. Calhoun. 1997. A practical guide to the diagnosis and management of bone and joint infections. Drugs 54, no. 2:253-264.
Malhotra, A., and D. P. White. 2002. Obstructive sleep apnoea. Lancet 360, no. 9,328:237-245.
Mankin, H. J. 1992. Nontraumatic necrosis of bone (osteonecrosis). New England Journal of Medicine 326, no. 22:1,473-1,479.
May, K. P.; S. G. West; M. R. Baker; and D. W. Everett. 1993. Sleep apnea in male patients with the fibromyalgia syndrome. American Journal of Medicine 94, no. 5:505-508.
Mayes, M. D. 2000. Photopheresis and autoimmune diseases. Rheumatic Diseases Clinics of North America 26, no. 1:75-81.
McGonagle, D.; P. G. Conaghan; and P. Emery. 1999. Pso-riatic arthritis: A unified concept twenty years on. Arthritis & Rheumatism 42, no. 6:1,080-1,086.
McGonagle, D.; S. Reade; H. Marzo-Ortega; et al. 2001. Human immunodeficiency virus associated spondy-loarthropathy: Pathogenic insights based on imaging findings and response to highly active antiretroviral treatment. Annals of the Rheumatic Diseases 60, no. 7:696-698.
Medina, P. J.; J. M. Sipols; and J. N. George. 2001. Drug-associated thrombotic thrombocytopenic purpura-
hemolytic uremic syndrome. Current Opinion in Hema-tology 8, no. 5:286-293.
Meeker, W. C., and S. Haldeman. 2002. Chiropractic: A profession at the crossroads of mainstream and alternative medicine. Annals of Internal Medicine 136, no. 3:216-227.
Merkel, P. A. 1999. Rheumatic disease and cystic fibrosis. Arthritis & Rheumatism 42, no. 8:1,563-1,571.
Meyer, U. A. 2000. Pharmacogenetics and adverse drug reactions. Lancet 356, no. 9,242:1,667-1,671.
Mitchell, H.; M. B. Bolster; and E. C. LeRoy. 1997. Scle-roderma and related conditions. Medical Clinics of North America 81, no. 1:129-149.
Moake, J. L. 2002. Thrombotic microangiopathies. New England Journal of Medicine 347, no. 8:589-600.
Moreland, L. W.; J. E. Brick; R. E. Kovach; et al. 1988. Acute febrile neutrophilic dermatosis (Sweet syndrome): A review of the literature with emphasis on musculoskeletal manifestations. Seminars in Arthritis & Rheumatism 17, no. 3:143-153.
Moriguchi, M.; C. Terai; H. Kaneko; et al. 2001. A novel single-nucleotide polymorphism at the 5'-flanking region of SAA1 associated with risk of type AA amy-loidosis secondary to rheumatoid arthritis. Arthritis & Rheumatism 44, no. 6:1,266-1,272.
Moseley, J. B.; K. O'Malley; N. J. Petersen; et al. 2002. A controlled trial of arthroscopic surgery for osteoarthri-tis of the knee. New England Journal of Medicine 347, no. 2:81-88.
Nadelman, R. B.; J. Nowakowski; D. Fish; et al. 2001. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. New England Journal of Medicine 345, no. 2:79-84.
Nadelman, R. B., and G. P. Wormser. 1998. Lyme borre-liosis. Lancet 352, no. 9,127:557-565.
Nangaku, M.; T. Miyata; and K. Kurokawa. 1999. Patho-genesis and management of dialysis-related amyloid bone disease. American Journal of the Medical Sciences 317, no. 6:410-415.
Natelson, B. H. 2001. Chronic fatigue syndrome. JAMA: Journal of the American Medical Association 285, no. 20:2,557-2,559.
Neves, O.; C. M. Stein; C. Thornton; I. Gangaidzo; and J. E. Thomas. 1991. Rhabdomyolysis associated with human immunodeficiency virus (HIV) infection. Central African Journal of Medicine 37, no. 11:387-388.
Newman, J. H.; L. Wheeler; K. B. Lane; et al. 2001. Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred. New England Journal of Medicine 345, no. 5:319-324.
Newman, L. S.; C. S. Rose; and L. A. Maier. 1997. Sar-coidosis. New England Journal of Medicine 336, no. 17:1,224-1,234.
O'Dell, J. R. 2002. Treating rheumatoid arthritis early: A window of opportunity? Arthritis & Rheumatism 46, no. 2:283-285.
Olin, J. W. 2000. Thromboangiitis obliterans (Buerger's disease). New England Journal of Medicine 343, no. 12:864-869.
Ortmann, R. A., and J. H. Klippel. 2000. Update on cyclophosphamide for systemic lupus erythematosus.
Rheumatic Diseases Clinics of North America 26, no. 2:363-375.
Ostensen, M. 1999. Sex hormones and pregnancy in rheumatoid arthritis and systemic lupus erythemato-sus. Annals of the New York Academy of Sciences 876:131-143.
Ostensen, M., and R. Ramsey-Goldman. 1998. Treatment of inflammatory rheumatic disorders in pregnancy: What are the safest treatment options? Drug Safety 19, no. 5:389-410.
Parkin, J., and B. Cohen. 2001. An overview of the immune system. Lancet 357, no. 9,270:1,777-1,789.
Petri, M. 1994. Systemic lupus erythematosus and pregnancy. Rheumatic Diseases Clinics of North America 20, no. 1:87-118.
---. 1998. Pregnancy in SLE. Baillieres Clinical
Rheumatology 12, no. 3:449-476.
Petri, M., D. Spence; L. R. Bone; and M. C. Hochberg. 1992. Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: Prevalence, recognition by patients, and preventive practices. Medicine 71, no. 5:291-302.
Pinals, R. S. 1994. Polyarthritis and fever. New England Journal of Medicine 330, no. 11:769-774.
Pincus, T.; R. H. Brooks; and L. F. Callahan. 1994. Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures. Annals of Internal Medicine 120, no. 1:26-34.
Pincus, T., and T. Sokka. 2001. Quantitative target values of predictors of mortality in rheumatoid arthritis as possible goals for therapeutic interventions: An alternative approach to remission or ACR20 responses? Journal of Rheumatology 28, no. 7:1,723-1,734.
Pincus, T. and C. M. Stein. 1999. ACR 20: Clinical or statistical significance? Arthritis & Rheumatism 42, no. 8:1,572-1,576.
Pincus, T.; C. M. Stein; and F. Wolfe. 1997. "No evidence of disease" in rheumatoid arthritis using methotrexate in combination with other drugs: A contemporary goal for rheumatology care? Clinical & Experimental Rheumatology 15, no. 6:591-596.
Pisetsky, D. S., and E. W. St. Clair. 2001. Progress in the treatment of rheumatoid arthritis. JAMA: Journal of the American Medical Association 286, no. 22:2,787-2,790.
Podolsky, D. K. 2002. Inflammatory bowel disease. New England Journal of Medicine 347, no. 6:417-429.
Puechal, X. 2001. Whipple disease and arthritis. Current Opinion in Rheumatology 13, no. 1:74-79.
Pyasta, R. T., and R. S. Panush. 1999. Common painful foot syndromes. Bulletin on the Rheumatic Diseases 48, no. 10:1-4.
Rao, J. K.; N. B. Allen; and T. Pincus. 1998. Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis. Annals of Internal Medicine 129, no. 5:345-352.
Raynauld, J. P. 1997. Cardiovascular mortality in rheumatoid arthritis: How harmful are corticos-teroids? Journal of Rheumatology 24, no. 3:415-416.
Reid, S.; T. Chalder; A. Cleare; et. 2000. Chronic fatigue syndrome. BMJ 320, no. 7,230:292-296.
Reveille, J. D. 2000. The changing spectrum of rheumatic disease in human immunodeficiency virus infection. Seminars in Arthritis & Rheumatism 30, no. 3:147-166.
Rho, R. H.; R. P. Brewer; T. J. Lamer; and P. R. Wilson. 2002. Complex regional pain syndrome. Mayo Clinic Proceedings 77, no. 2:174-180.
Rhodes, J. M. 1996. Cholesterol crystal embolism: An important "new" diagnosis for the general physician. Lancet 347, no. 9,016:1,641.
Robinson, W. H.; M. C. Genovese; and L. W. Moreland. 2001. Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: By what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis & Rheumatism 44, no. 9:1,977-1,983.
Roden, D. M., and A. L. George, Jr. 2002. The genetic basis of variability in drug responses. Nature Reviews. Drug Discovery 1, no. 1:37-44.
Rose, S.; M. A. Young; and J. C. Reynolds. 1998. Gastrointestinal manifestations of scleroderma. Gastroenterology Clinics of North America 27, no. 3:563-594.
Roses, A. D. 2000. Pharmacogenetics and the practice of medicine. Nature 405, no. 6,788:857-865.
Rosner, I. A.; C. G. Burg; J. J. Wisnieski; et al. 1993. The clinical spectrum of the arthropathy associated with hidradenitis suppurativa and acne conglobata. Journal of Rheumatology 20, no. 4:684-687.
Rowe, P. C.; H. Calkins; K. DeBusk; et al. 2001. Fludro-cortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: A randomized controlled trial. JAMA: Journal of the American Medical Association 285, no. 1:52-59.
Rubin, L. J. 1997. Primary pulmonary hypertension. New England Journal of Medicine 336, no. 2:111-117.
Rubin, L. J.; D. B. Badesch; R. J. Barst; et al. 2002. Bosen-tan therapy for pulmonary arterial hypertension. New England Journal of Medicine 346, no. 12:896-903.
Ruddy, S.; E. D. Harris; and C. B. Sledge. 2000. Kelley's Textbook of Rheumatology, 6th edition. Philadelphia: W.B. Saunders.
Sakane, T.; M. Takeno; N. Suzuki; and G. Inaba. 1999. Behçet's disease. New England Journal of Medicine 341, no. 17:1,284-1,291.
Salvarani, C.; F. Cantini; L. Boiardi; and G. G. Hunder. 2002. Polymyalgia rheumatica and giant-cell arteritis. New England Journal of Medicine 347, no. 4:261-271.
Samuels, J.; I. Aksentijevich; Y. Torosyan; et al. 1998. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine 77, no. 4:268-297.
Sapadin, A. N., and R. Fleischmajer. 2002. Treatment of scleroderma. Archives of Dermatology 138, no. 1:99-10S.
Schott, G. D. 2001. Reflex sympathetic dystrophy. Journal of Neurology, Neurosurgery & Psychiatry 71, no. 3:291-295.
Schwartzman, R. J. 2000. New treatments for reflex sympathetic dystrophy. New England Journal of Medicine 343, no. 9:654-656.
Sergent, J. S. 1983. Extrahepatic manifestations of hepatitis B infection. Bulletin on the Rheumatic Diseases 33, no. 6:1-6.
Shojania, K. 2000. Rheumatology: 2. What laboratory tests are needed? CMAJ: Canadian Medical Association Journal 162, no. 8:1,157-1,163.
Smith, J. R., and J. T. Rosenbaum. 2002. Management of uveitis: A rheumatologic perspective. Arthritis & Rheumatism 46, no. 2:309-318.
Smith, J. W. 1990. Infectious arthritis. Infectious Disease Clinics of North America 4, no. 3:523-538.
Sokka, T.; H. Kautiainen; T. Mottonen; and P. Hannonen. 1999. Work disability in rheumatoid arthritis 10 years after the diagnosis. Journal of Rheumatology 26, no. 8:1,681-1,685.
Sokka, T., and T. Pincus. 2001. Markers for work disability in rheumatoid arthritis. Journal of Rheumatology 28, no. 7:1,718-1,722.
St. Clair E. W., and R. M. McCallum. 1999. Cogan's syndrome. Current Opinion in Rheumatology 11, no. 1:47-52.
Steere, A. C. 2001. Lyme disease. New England Journal of Medicine 345, no. 2:115-125.
Stein, C. M. 2001. Arthritis Medicines A-Z: A Doctor's Guide to Today's Most Commonly Prescribed Arthritis Drugs. New York: Crown.
Stein, C. M.; N. Brown; D. E. Vaughan; et al. 1998. Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature. Journal of the American College of Cardiology 32, no. 1:117-122.
Stein, C. M. and P. Davis. 1996. Arthritis associated with HIV infection in Zimbabwe. Journal of Rheumatology 23, no. 3:506-511.
Stein, C. M., and T. Pincus. 1999. Placebo-controlled studies in rheumatoid arthritis: Ethical issues. Lancet 353, no. 9,150:400-403.
Stein, C. M.; T. Pincus; D. Yocum; et al. 1997. Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks: An open-label extension study. The Methotrexate-Cyclosporine Combination Study Group. Arthritis & Rheumatism 40, no. 10:1,843-1,851.
Stein, C. M., and J. E. Thomas. 1991. Behcet's disease associated with HIV infection. Journal of Rheumatology 18, no. 9:1,427-1,428.
Steinfeld, R.; R. M. Valente; and M. J. Stuart. 1999. A commonsense approach to shoulder problems. Mayo Clinic Proceedings 74, no. 8:785-794.
Stollerman, G. H. 1997. Rheumatic fever. Lancet 349, no. 9,056:935-942.
Stone, J. H.; G. S. Hoffman; P. A. Merkel; et al. 2001. A disease-specific activity index for Wegener's granulo-matosis: Modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis & Rheumatism 44, no. 4:912-920.
Sule, S. D., and F. M. Wigley. 2000. Update on management of scleroderma. Bulletin on the Rheumatic Diseases 49, no. 10:1-4.
Totemchokchyakarn, K., and G. V. Ball. 1997. Sarcoid arthropathy. Bulletin on the Rheumatic Diseases 46, no. 3:3-5.
Trock, D. H. 2000. Electromagnetic fields and magnets. Investigational treatment for musculoskeletal disorders. Rheumatic Diseases Clinics of North America 26, no. 1:51-62.
Tugwell, P.; T. Pincus; D. Yocum; M. Stein; O. Gluck; G. Kraag; R. McKendry; J. Tesser; P. Baker; and G. Wells. 1995. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group. New England Journal of Medicine 333, no. 3:137-141.
Tugwell, P.; G. Wells; J. Peterson; et al. 2001. Do silicone breast implants cause rheumatologic disorders? A systematic review for a court-appointed national science panel. Arthritis & Rheumatism 44, no. 11:2,477-2,484.
Tyndall, A. and EBMT/EULAR International Data Base. 2001. Autologous hematopoietic stem cell transplantation for severe autoimmune disease with special reference to rheumatoid arthritis. Journal of Rheumatology 28, Suppl. 64:5-7.
Tyndall, A., and T. Koike. 2002. High-dose immunoablative therapy with hematopoietic stem cell support in the treatment of severe autoimmune disease: current status and future direction. Internal Medicine 41, (8):608-12.
Uhl, T. L., and J. A. Madaleno. 2001. Rehabilitation concepts and supportive devices for overuse injuries of the upper extremities. Clinics in Sports Medicine 20, no. 3:621-639.
Urowitz, M. B.; D. D. Gladman; M. Abu-Shakra; and V. T. Farewell. 1997. Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years. Journal of Rheumatology 24, no. 6:1,061-1,065.
Van Doornum, S.; G. McColl; and I. P. Wicks. 2002. Accelerated atherosclerosis: An extraarticular feature of rheumatoid arthritis? Arthritis & Rheumatism 46, no. 4:862-873.
Vassilopoulos, D., and L. H. Calabrese. 1998. Rheumato-logic manifestations of HIV-1 and HTLV-1 infections. Cleveland Clinic Journal of Medicine 65, no. 8:436-441.
--. 2002. Hepatitis C virus infection and vasculitis:
Implications of antiviral and immunosuppressive therapies. Arthritis & Rheumatism 46, no. 3:585-597.
Vergne, P.; P. Bertin; C. Bonnet; et al. 2000. Drug-induced rheumatic disorders: Incidence, prevention and management. Drug Safety 23, no. 4:279-293.
Walker, A. M.; D. Funch; N. A. Dreyer; et al. 1993. Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis. Arthritis & Rheumatism 36, no. 3:329-335.
Walport, M. J. 2001. Complement. First of two parts. New England Journal of Medicine 344, no. 14:1,058-1,066.
--. 2001. Complement. Second of two parts. New
England Journal of Medicine 344, no. 15:1,140-1,144.
Ward, M. M.; J. P. Leigh; and J. F. Fries. 1993. Progression of functional disability in patients with rheumatoid arthritis. Associations with rheumatology subspecialty care. Archives of Internal Medicine 153, no. 19:2,229-2,237.
Ward, M. M.; E. Pyun; and S. Studenski. 1995. Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort. Arthritis & Rheumatism 38, no. 10:1,492-1,499.
Weinblatt, M. E.; J. M. Kremer; A. D. Bankhurst; et al. 1999. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. New England Journal of Medicine 340, no. 4:253-259.
Wener, M. H.; R. J. Johnson; E. H. Sasso; and D. R. Gretch. 1996. Hepatitis C virus and rheumatic disease. Journal of Rheumatology 23, no. 6:953-959.
White, B.; W. C. Moore; F. M. Wigley; et al. 2000. cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Annals of Internal Medicine 132, no. 12:947-954.
Wigley, F. M. 2002. Raynaud's Phenomenon. New England Journal of Medicine 347, no. 13:1,001-1,008.
Wolfe, F.; D. M. Mitchell; J. T. Sibley; et al. 1994. The mortality of rheumatoid arthritis. Arthritis & Rheumatism 37, no. 4:481-494.
Wolfe, F.; J. J. Cush; J. R. O'Dell; et al. 2001. Consensus recommendations for the assessment and treatment of rheumatoid arthritis. Journal of Rheumatology 28, no. 6:1,423-1,430.
Wolfe, F.; J. R. O'Dell; A. Kavanaugh; et al. 2001. Evaluating severity and status in rheumatoid arthritis. Journal of Rheumatology 28, no. 6:1,453-1,462.
Wolfe, F.; Q. Rehman; N. E. Lane; and J. Kremer. 2001. Starting a disease modifying antirheumatic drug or a biologic agent in rheumatoid arthritis: Standards of practice for RA treatment. Journal of Rheumatology 28, no. 7:1,704-1,711.
Yassi; A. 1997. Repetitive strain injuries. Lancet 349, no. 9,056:943-947.
--. 2000. Work-related musculoskeletal disorders.
Current Opinion in Rheumatology 12, no. 2:124-130.
Yocum, D. E.; W. L. Castro; and M. Cornett. 2000. Exercise, education, and behavioral modification as alternative therapy for pain and stress in rheumatic disease. Rheumatic Diseases Clinics of North America 26, no. 1:145-159.
Ytterberg, S. R. 1999. Viral arthritis. Current Opinion in Rheumatology 11, no. 4:275-280.
Zemer, D.; M. Pras; E. Sohar; et al. 1986. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. New England Journal of Medicine 314, no. 16:1,001-1,005.
Zuckner, J. 1994. Drug-related myopathies. Rheumatic Diseases Clinics of North America 20, no. 4:1,017-1,032.
Was this article helpful?
Thank you for deciding to learn more about the disorder, Osteoarthritis. Inside these pages, you will learn what it is, who is most at risk for developing it, what causes it, and some treatment plans to help those that do have it feel better. While there is no definitive “cure” for Osteoarthritis, there are ways in which individuals can improve their quality of life and change the discomfort level to one that can be tolerated on a daily basis.